GLENVIEW CAPITAL MANAGEMENT, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1138995
Institutional-grade research for retail investors
Email me the moment this fund files its next 13F

13F Reported Value

$5.5B

incl. option notional

Equity Holdings

$5.0B

Option Notional

$485.5M

$470.0M puts / $15.5M calls

Holdings

45

Latest Filing

2026-06-30

Filing Quarter

Q2 2026

Portfolio Overview

GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 45 positions worth $5.5B in its Form 13F-HR for Q2 2026$5.0B in common stock plus $485.5M of put/call option positions (reported at underlying notional value, not premium at risk), led by $GPN (GLOBAL PAYMENTS INC) at 12.9% of the equity portfolio, followed by $CVS and $THC. During the quarter the fund opened 14 new positions and exited 13 — including a new stake in $A and a full exit from $QQQ. The portfolio is most concentrated in Healthcare (39.6% of disclosed assets). All figures are sourced directly from GLENVIEW CAPITAL MANAGEMENT, LLC’s Form 13F-HR filing with the SEC under CIK 1138995.

Sector Allocation

HealthcareTechnologyIndustrialsConsumer DiscretionaryCommunication ServicesMaterials

AUM History

Top Equity Holdings by Value

Option Positions

13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.

ISHARES TR - RUSSELL 2000 ETFPUT$276M notional
$SPYPUT$194M notional
$ACALL$15M notional

Quarterly Activity — Q2 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of GLENVIEW CAPITAL MANAGEMENT, LLC's 45 positions.

Showing top 10 of 45 holdings.

Sector Allocation

Healthcare

$2.0B

Technology

$1.7B

Industrials

$713.5M

Consumer Discretionary

$394.1M

Communication Services

$124.8M

Materials

$47.5M

Energy

$27.4M

Consumer Staples

$14.2M

Full Holdings — GLENVIEW CAPITAL MANAGEMENT, LLC (Q2 2026)

All 45 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

TickerCompanyValue
GPN$GPNGLOBAL PAYMENTS INC$646.3M
CVS$CVSCVS HEALTH Corp$499.1M
THC$THCTENET HEALTHCARE CORP$418.2M
TMO$TMOTHERMO FISHER SCIENTIFIC INC.$314.5M
AMZN$AMZNAMAZON COM INC$303.1M
ISHARES TR - RUSSELL 2000 ETF$275.9M
A$AAGILENT TECHNOLOGIES, INC.$261.6M
DHR$DHRDANAHER CORP /DE/$218.3M
META$METAMeta Platforms, Inc.$201.0M
SPY$SPYPUTSPDR S&P 500 ETF TRUST$194.2M
AMD$AMDADVANCED MICRO DEVICES INC$173.3M
TEVA$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD$172.1M
VTRS$VTRSViatris Inc$156.9M
UBER$UBERUber Technologies, Inc$129.4M
CNC$CNCCENTENE CORP$121.1M
BFLY$BFLYButterfly Network, Inc.$120.7M
CI$CICigna Group$113.6M
HUM$HUMHUMANA INC$101.0M
XYZ$XYZBlock, Inc.$91.0M
DKS$DKSDICK'S SPORTING GOODS, INC.$91.0M
GENI$GENIGenius Sports Ltd$81.8M
ONTO$ONTOONTO INNOVATION INC.$77.9M
LLY$LLYELI LILLY & Co$69.3M
UAL$UALUnited Airlines Holdings, Inc.$67.3M
EYE$EYENational Vision Holdings, Inc.$59.0M
CSCO$CSCOCISCO SYSTEMS, INC.$48.5M
ESI$ESIElement Solutions Inc$47.5M
AMAT$AMATAPPLIED MATERIALS INC /DE$47.1M
MKSI$MKSIMKS INC$43.8M
FUN$FUNSix Flags Entertainment Corporation/NEW$43.0M
STM$STMSTMicroelectronics N.V.$41.9M
ABBV$ABBVAbbVie Inc.$37.5M
AZN$AZNASTRAZENECA PLC$34.9M
BLCO$BLCOBausch & Lomb Corp$31.8M
BKR$BKRBaker Hughes Co$27.4M
ELV$ELVElevance Health, Inc.$25.8M
MCHP$MCHPMICROCHIP TECHNOLOGY INC$24.2M
A$ACALLAGILENT TECHNOLOGIES, INC.$15.5M
BRKR$BRKRBRUKER CORP$15.2M
NVS$NVSNOVARTIS AG$13.6M
DOCN$DOCNDigitalOcean Holdings, Inc.$13.3M
PRMB$PRMBPrimo Brands Corp$9.9M
BSX$BSXBOSTON SCIENTIFIC CORP$4.8M
CAH$CAHCARDINAL HEALTH INC$4.3M
TECH$TECHBIO-TECHNE Corp$4.1M

New Positions (14)

A$A AGILENT TECHNOLOGIES, INC.$261.6M
SPY$SPYPUT SPDR S&P 500 ETF TRUST$194.2M
LLY$LLY ELI LILLY & Co$69.3M
MKSI$MKSI MKS INC$43.8M
STM$STM STMicroelectronics N.V.$41.9M
ABBV$ABBV AbbVie Inc.$37.5M
AZN$AZN ASTRAZENECA PLC$34.9M
ELV$ELV Elevance Health, Inc.$25.8M
MCHP$MCHP MICROCHIP TECHNOLOGY INC$24.2M
A$ACALL AGILENT TECHNOLOGIES, INC.$15.5M
BRKR$BRKR BRUKER CORP$15.2M
NVS$NVS NOVARTIS AG$13.6M
BSX$BSX BOSTON SCIENTIFIC CORP$4.8M
CAH$CAH CARDINAL HEALTH INC$4.3M

Exited Positions (13)

QQQ$QQQCALL INVESCO QQQ TRUST, SERIES 1
DXC$DXC DXC Technology Co
GTM$GTM ZoomInfo Technologies Inc.
USFD$USFD US Foods Holding Corp.
Z$Z ZILLOW GROUP, INC.
LAD$LAD LITHIA MOTORS INC
LION$LION Lionsgate Studios Corp.
MYGN$MYGN MYRIAD GENETICS INC
SGRY$SGRY Surgery Partners, Inc.
AKAM$AKAM AKAMAI TECHNOLOGIES INC
INTC$INTC INTEL CORP
BIIB$BIIB BIOGEN INC.
GPN$GPNCALL GLOBAL PAYMENTS INC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for GLENVIEW CAPITAL MANAGEMENT, LLC including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track GLENVIEW CAPITAL MANAGEMENT, LLC's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for GLENVIEW CAPITAL MANAGEMENT, LLC and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: GLENVIEW CAPITAL MANAGEMENT, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For GLENVIEW CAPITAL MANAGEMENT, LLC (SEC CIK: 1138995), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.